Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Willdan Group
WLDN
$1.04B
| $365K | ﹤0.01% |
+12,600
| New | +$274K |
|
3002
Coherus Oncology
CHRS
$217M
| $364K | ﹤0.01% |
+152,328
| New | +$375K |
|
|
SCS
3003
DELISTED
Steelcase
SCS
| $364K | ﹤0.01% |
27,800
-143,100
| -84% | -$1.84M |
|
3004
Capricor Therapeutics
CAPR
$223M
| $361K | ﹤0.01% |
53,150
-93,171
| -64% | -$451K |
|
3005
Karooooo
KARO
$1.98B
| $361K | ﹤0.01% |
14,401
+1,900
| +15% | +$47.5K |
|
3006
Cartesian Therapeutics
RNAC
$229M
| $360K | ﹤0.01% |
18,453
+1,193
| +7% | +$25.3K |
|
|
ZH
3007
Zhihu
ZH
$281M
| $360K | ﹤0.01% |
87,617
| – | – |
|
|
VBNK
3008
VersaBank
VBNK
$623M
| $358K | ﹤0.01% |
33,815
+21,315
| +171% | +$236K |
|
|
XYF
3009
X Financial
XYF
$190M
| $358K | ﹤0.01% |
92,675
-2,900
| -3% | -$11.9K |
|
3010
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
| $357K | ﹤0.01% |
+10,200
| New | +$383K |
|
3011
Oramed Pharmaceuticals
ORMP
$167M
| $357K | ﹤0.01% |
122,100
-218,973
| -64% | -$612K |
|
|
REE
3012
DELISTED
REE Automotive
REE
| $357K | ﹤0.01% |
61,077
+3,600
| +6% | +$21.8K |
|
3013
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $355K | ﹤0.01% |
+8,300
| New | +$350K |
|
3014
GEE Group
JOB
$23.1M
| $355K | ﹤0.01% |
987,629
+90,237
| +10% | +$37.5K |
|
|
NREF
3015
NexPoint Real Estate Finance
NREF
$320M
| $355K | ﹤0.01% |
24,700
-6,000
| -20% | -$87.7K |
|
3016
Steven Madden
SHOO
$3.37B
| $355K | ﹤0.01% |
8,400
-153,300
| -95% | -$6.46M |
|
3017
UTStarcom
UTSI
$23.5M
| $355K | ﹤0.01% |
136,629
-16,897
| -11% | -$48.6K |
|
3018
Avantis Emerging Markets Equity ETF
AVEM
$25.4B
| $354K | ﹤0.01% |
+6,100
| New | +$343K |
|
3019
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $354K | ﹤0.01% |
14,883
+1,494
| +11% | +$35.6K |
|
3020
Bristow Group
VTOL
$1.34B
| $354K | ﹤0.01% |
13,000
-12,300
| -49% | -$328K |
|
3021
Sonos
SONO
$1.73B
| $353K | ﹤0.01% |
+18,500
| New | +$328K |
|
3022
-1x Short VIX Futures ETF
SVIX
$174M
| $352K | ﹤0.01% |
+8,300
| New | +$330K |
|
|
VZLA
3023
Vizsla Silver
VZLA
$1.1B
| $352K | ﹤0.01% |
265,000
-76,152
| -22% | -$97.8K |
|
3024
Sportsman's Warehouse
SPWH
$44.5M
| $350K | ﹤0.01% |
112,700
+66,400
| +143% | +$247K |
|
3025
iShares MSCI World ETF
URTH
$7.99B
| $348K | ﹤0.01% |
2,400
-9,700
| -80% | -$1.34M |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.